Related Experiment Video
Updated: Jun 10, 2026

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
Ca2+/calmodulin-dependent kinase IIdelta causes heart failure by accumulation of p53 in dilated cardiomyopathy
Haruhiro Toko1, Hidehisa Takahashi, Yosuke Kayama
1Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
Background:
Dilated cardiomyopathy (DCM), characterized by dilatation and dysfunction of the left ventricle, is an important cause of heart failure. Many mutations in various genes, including cytoskeletal protein genes and contractile protein genes, have been identified in DCM patients, but the mechanisms of how such mutations lead to DCM remain unknown.
Methods And Results:
We established the mouse model of DCM by expressing a mutated cardiac alpha-actin gene, which has been reported in patients with DCM, in the heart (mActin-Tg). mActin-Tg mice showed gradual dilatation and dysfunction of the left ventricle, resulting in death by heart failure. The number of apoptotic cardiomyocytes and protein levels of p53 were increased in the hearts of mActin-Tg mice. Overexpression of Bcl-2 or downregulation of p53 decreased the number of apoptotic cardiomyocytes and improved cardiac function. This mouse model showed a decrease in myofilament calcium sensitivity and activation of calcium/calmodulin-dependent kinase IIdelta (CaMKIIdelta). The inhibition of CaMKIIdelta prevented the increase in p53 and apoptotic cardiomyocytes and ameliorated cardiac function.
Conclusions:
CaMKIIdelta plays a critical role in the development of heart failure in part by accumulation of p53 and induction of cardiomyocyte apoptosis in the DCM mouse model.
Insights
A mutated cardiac alpha-actin gene caused dilated cardiomyopathy (DCM) in mice, leading to heart failure. Calcium/calmodulin-dependent kinase IIdelta (CaMKIIdelta) activation contributes to DCM by increasing p53 and cardiomyocyte apoptosis.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Genetics of Heart Disease
Background:
- Dilated cardiomyopathy (DCM) is a major cause of heart failure, characterized by left ventricular dilation and dysfunction.
- Genetic mutations, particularly in cytoskeletal and contractile protein genes, are implicated in DCM, but underlying mechanisms remain unclear.
Purpose of the Study:
- To establish and characterize a mouse model of DCM using a mutated cardiac alpha-actin gene.
- To investigate the molecular mechanisms linking genetic mutations to DCM pathogenesis and heart failure.
Main Methods:
- Generation of transgenic mice (mActin-Tg) expressing a DCM-associated mutated cardiac alpha-actin gene.
- Assessment of cardiac function, cardiomyocyte apoptosis, p53 protein levels, myofilament calcium sensitivity, and CaMKIIdelta activity in mActin-Tg mice.
- Pharmacological inhibition of CaMKIIdelta to evaluate its role in DCM progression.
Main Results:
- mActin-Tg mice exhibited progressive left ventricular dilatation, dysfunction, and heart failure, mimicking human DCM.
- Increased cardiomyocyte apoptosis and elevated p53 levels were observed in mActin-Tg hearts.
- Reduced myofilament calcium sensitivity and activated CaMKIIdelta were detected.
- Inhibition of CaMKIIdelta attenuated cardiomyocyte apoptosis, improved cardiac function, and reduced p53 accumulation.
Conclusions:
- CaMKIIdelta plays a crucial role in DCM pathogenesis and heart failure development.
- CaMKIIdelta contributes to DCM by promoting p53 accumulation and cardiomyocyte apoptosis.
- This mActin-Tg mouse model provides a valuable tool for studying DCM mechanisms and testing therapeutic strategies.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Heart Failure II: Pathophysiology
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy